Articles publiés

Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.

Bouquet E, Eiden C, Fauconneau B, Pion C; French Addictovigilance Network (FAN), Pain S, Pérault-Pochat MC. Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020. Sci Rep. 2022 Oct 3;12(1):16509. doi: 10.1038/s41598-022-19197-2. PMID: 36192621.

Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020. Lire la suite »

A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist

Pain S, Bouquet E, Coulon M, Fauconneau B, Perault-Pochat MC. A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):500-501. doi: 10.1097/JCP.0000000000001578. Epub 2022 Aug 6. PMID: 35943411.

A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist Lire la suite »

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale.

Kerckhove N, Delage N, Bertin C, Kuhn E, Cantagrel N, Vigneau C, Delorme J, Lambert C, Pereira B, Chenaf C, Authier N; Poma Network. Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale. Front Pharmacol. 2022 Sep 5;13:947006. doi:

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale. Lire la suite »

What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion

Carton L, Icick R, Weibel S, Dematteis M, Kammerer E, Batisse A, Rolland B. What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion. Expert Rev Clin Pharmacol. 2022 Aug 18:1-5. doi: 10.1080/17512433.2022.2112950. Epub ahead of print. PMID: 35959655.

What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion Lire la suite »

Minors and young adult’s hospitalizations after « chimique » consumption in Mayotte Island: Which substances are involved?

Goncalves R, Peyré A, Castaing N, Beeken T, Olivier S, Combe P, Miremont-Salamé G, Titier K, Molimard M, Daveluy A. Minors and young adult’s hospitalizations after « chimique » consumption in Mayotte Island: Which substances are involved? Therapie. 2022 Aug 1:S0040-5957(22)00124-X. doi: 10.1016/j.therap.2022.07.007. Epub ahead of print. PMID: 36064627.

Minors and young adult’s hospitalizations after « chimique » consumption in Mayotte Island: Which substances are involved? Lire la suite »

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users.

Laforgue EJ, Rousselet M, Claudon A, Aquizerate A, Jolliet P, Istvan M, Victorri-Vigneau C. Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users. Int J Environ Res Public Health. 2022 Jul 22;19(15):8920. doi: 10.3390/ijerph19158920. PMID: 35897285; PMCID: PMC9331950.

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users. Lire la suite »

Hospitalisations après consommation de substances psychoactives pendant la pandémie de Covid-19

Dumoulin C, Ong N, Ramaroson H, Létinier L, Miremont-Salamé G, Gilleron V, Daveluy A, Perino J. Hospitalisations après consommation de substances psychoactives pendant la pandémie de Covid-19 [Hospitalizations after substance use during the COVID-19 pandemic]. Therapie. 2022 Jun 30:S0040-5957(22)00108-1. French. doi: 10.1016/j.therap.2022.06.003. Epub ahead of print. PMID: 35908997;  PMCID: PMC9329723. 

Hospitalisations après consommation de substances psychoactives pendant la pandémie de Covid-19 Lire la suite »

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database

Revol B, Lapeyre-Mestre M, Fouilhé Sam-Laï N, Jouanjus E. Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. Br J Clin Pharmacol. 2022 Jun 4. doi: 10.1111/bcp.15430. Epub ahead of print. PMID: 35665950.

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database Lire la suite »

Retour en haut